|
Market Closed -
NYSE
00:00:02 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.71 USD | -3.78% |
|
-0.51% | +9.64% |
| 08-28 | Medifast Insider Bought Shares Worth $529,157, According to a Recent SEC Filing | MT |
| 08-27 | Medifast Announces Launch of Medifast Metabolic Health Institute | CI |
Company Valuation: Medifast, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,424 | 1,253 | 724.4 | 187.7 | 109.8 | 121.1 | - |
| Change | - | -48.3% | -42.2% | -74.09% | -41.52% | 10.3% | - |
| Enterprise Value (EV) | 2,314 | 1,166 | 630 | 25.34 | 109.8 | 121.1 | 121.1 |
| Change | - | -49.64% | -45.95% | -95.98% | 333.13% | 10.3% | 0% |
| P/E | 15.1x | 9.06x | 7.39x | 92.7x | -6.28x | -12.5x | -41.8x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -1.08x | -0.3x | -0.9x | 0x | 0.3x | 0.6x |
| Capitalization / Revenue | 1.59x | 0.78x | 0.68x | 0.31x | - | 0.42x | 0.44x |
| EV / Revenue | 0x | 0x | 0x | 0x | - | 0.42x | 0.44x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 27.5x | 8.41x |
| EV / EBIT | 0x | 0x | 0x | 0x | - | -7.52x | -22.4x |
| EV / FCF | 0x | 0x | - | 0x | 0x | -37.8x | 10.2x |
| FCF Yield | 2.49% | 14.2% | - | 9.07% | 1.14% | -2.64% | 9.83% |
| Dividend per Share 2 | 5.68 | - | - | - | - | - | - |
| Rate of return | 2.71% | - | - | - | - | - | - |
| EPS 2 | 13.89 | 12.73 | 9.1 | 0.19 | -1.7 | -0.94 | -0.28 |
| Distribution rate | 40.9% | - | - | - | - | - | - |
| Net sales 1 | 1,526 | 1,599 | 1,072 | 602.5 | - | 287.7 | 273.7 |
| EBITDA 1 | 223.1 | 227 | 147.1 | 43.03 | 7.668 | 4.4 | 14.4 |
| EBIT 1 | 216.2 | 216 | 134 | 22.96 | - | -16.1 | -5.4 |
| Net income 1 | 164 | 143.6 | 99.42 | 2.091 | - | -10.5 | -3.1 |
| Net Debt | -109.5 | -87.69 | -94.44 | -162.3 | - | - | - |
| Reference price 2 | 209.43 | 115.35 | 67.22 | 17.62 | 10.68 | 11.71 | 11.71 |
| Nbr of stocks (in thousands) | 11,574 | 10,865 | 10,777 | 10,652 | 10,277 | 10,339 | - |
| Announcement Date | 23/02/22 | 21/02/23 | 20/02/24 | 18/02/25 | 17/02/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.95x | - | - | - | 126M | |
| 8.81x | 2.72x | 5.72x | 4.91% | 11.75B | |
| 41.44x | 12.25x | 39.11x | 0.7% | 9.16B | |
| 21.93x | 2.15x | 12.62x | 3.62% | 2.32B | |
| 18.83x | - | - | - | 1.46B | |
| 8.15x | - | - | -.--% | 1.32B | |
| 6.73x | 0.82x | 6.74x | -.--% | 920M | |
| -5.65x | 0.82x | 4.96x | -.--% | 849M | |
| Average | 10.91x | 3.75x | 13.83x | 1.54% | 3.49B | |
| Weighted average by Cap. | 20.50x | 6.02x | 18.61x | 2.76% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MED Stock
- Valuation Medifast, Inc.
Select your edition
All financial news and data tailored to specific country editions
